Hyphens Pharma (SGX: 1J5): Sustainable Growth Momentum and Attractive Outlook
Hyphens Pharma is Singapore’s leading specialty pharmaceutical and consumer healthcare group, leveraging on its diverse footprints in ASEAN...
55 Views
Health Horizons: Singapore's Rising Stars in Biotech & Medtech
Singapore’s healthcare and life sciences sector presents a compelling structural growth opportunity in 2026. In our view, two complementary...
144 Views
The Week That Was in ASEAN@Smartkarma - Alfamart's Guidance, Indonesia's Pragmatism, and Thai Banks
The past week saw insights on Sumber Alfaria Trijaya (AMRT IJ, SLB Development (SLB SP), Japfa Ltd (JAP SP), Hyphens Pharma International (HYP SP),...
766 Views
PharmaEssentia GDS Issuance - Strong Revenue Growth and Narrowing Losses
Pharmaessentia Corp (6446 TT) aims to raise around US$412m (TWD12.6bn) via a GDS issuance. In this note, we will talk about the deal dynamics and...
1.1k Views
Thomson Medical (TMG SP)/Tmc Life Sciences (TMCL MK): Strong Recovery; Scale Expansion to Aid Growth
Thomson Medical, with predominant focus on gynecology and pediatrics, is well-positioned to benefit from Singapore and Malaysia re-opening. Recent...
673 Views